Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThomas Engstrøm, Lars Køber, Kari Saunamäki et al.|The Lancet|2015Cited by 966
Beta-Blockers after Myocardial Infarction in Patients without Heart FailureJohn Munkhaugen, Gro Egholm, Anna Meta Dyrvig Kristensen et al.|New England Journal of Medicine|2025Cited by 73
Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial InfarctionJasmine Melissa Madsen, Jacob Thomsen Lønborg, Thomas Engstrøm et al.|JAMA Cardiology|2024Cited by 18
Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)Jasmine Melissa Madsen, Jacob Thomsen Lønborg, Laust Emil Roelsgaard Obling et al.|Trials|2023Cited by 8